as on March 10, 2026 at 6:59 am IST
Day's Low
Day's High
3.31%
Downside
0.65%
Upside
52 Week's Low
52 Week's High
1.60%
Downside
52.29%
Upside
Check Boston Scientific Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$105.9B
EPS (TTM)
3.4713
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.18%
PE Ratio (TTM)
36.78
Industry PE ratio
17.642820512820514
PEG Ratio
0.7928
EBITDA
5.3B
Revenue (TTM)
20.1B
Profit Margin
14.44%
Return On Equity TTM
12.45%
Track how Boston Scientific Corp. P/E has moved over time to understand its valuation trends.
Boston Scientific Corp. in the last 5 years
Lowest (23.46x)
September 30, 2022
Industry (17.64x)
March 9, 2026
Today (36.78x)
March 9, 2026
Highest (37.29x)
March 31, 2025
Today’s Price to Earnings Ratio: 36.78x
Compare market cap, revenue, PE, and other key metrics of Boston Scientific Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $105.9B | 80.4% | 36.78 | 14.44% | |
| BUY | $139.5B | 53.71% | 43.5 | 12.92% | |
| BUY | $116.7B | -22.34% | 25.39 | 13.00% | |
| BUY | $190.4B | -6.12% | 29.37 | 14.72% | |
| BUY | $47.4B | -0.46% | 45.1 | 17.69% |
The Boston Scientific Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Boston Scientific Corp. investment value today
Current value as on today
₹78,265
Returns
Returns from Boston Scientific Corp. Stock
Dollar Returns*
₹5,734 (+5.73%)
Based on 37 analysts
91.89%
Buy
8.11%
Hold
0.00%
Sell
Based on 37 analysts, 91.89% of analysts recommend a 'BUY' rating for Boston Scientific Corp.. Average target price of $104.24
Get share price movements and forecasts by analysts on Boston Scientific Corp..
What analysts predicted
31.02%UPSIDE
Target Price
$104.24
Current Price
$71.9
Analyzed by
37 Analysts
Target
$104.24
Boston Scientific Corp. target price $104.24, a slight upside of 31.02% compared to current price of $71.9. According to 37 analysts rating.
Investment in Boston Scientific Corp. Shares on INDmoney has grown by 9.44% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:9.44%Â versus previous 30 day period
Search interest for Boston Scientific Corp. Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 February
Thu, 02:06 PM
-Boston Scientific's stock declines 27.5% over three months, underperforming the Dow despite strong Q4 results.
Thu, 09:05 PM
-New options for Boston Scientific available; put and call contracts identified with potential returns.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Boston Scientific Corp. has shown consistent growth in its revenue over the last 10 quarters. Starting from $3.52 billion, the revenue has increased to $5.28 billion, with an average growth of 4.4% each quarter.
Best in 3 Years
![]()
In the last 3 years, BSX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 19.1% return, outperforming this stock by 43.3%
Profit Down
![]()
Boston Scientific Corp. has seen a decline in its net profit for the last three quarters. The net profit decreased from $793.0 million to $668.0 million, resulting in an average decrease of 8.2% each quarter.
Price Dip
![]()
In the last 3 months, BSX stock has moved down by -23.0%
| Organisation | Boston Scientific Corp. |
| Headquarters | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 |
| Industry | Health Technology |
| CEO | Mr. Michael F. Mahoney |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Vance R. Brown J.D. | Senior VP, General Counsel & Corporate Secretary |
Ms. Brenda Becker | Senior Vice President of Global Government Affairs |
Ms. Miriam O'sullivan | Senior VP & Chief Human Resources Officer |
Mr. Michael F. Mahoney | Chairman, President & CEO |
Mr. Joseph M. Fitzgerald | Executive VP & Group President of Cardiology |
Mr. Arthur Crosswell Butcher | Executive VP and Group President of MedSurg & Asia Pacific |
Mr. Jonathan R. Monson | Executive VP & CFO |
Mr. Paudie O'Connor | Executive Vice President of Global Operations |
Ms. Emily M. Woodworth | Senior VP, Global Controller & Chief Accounting Officer |
Mr. Adam Smith | General Manager of Global Sales & Marketing |
Boston Scientific Corp. share price today is $71.9 as on at the close of the market. Boston Scientific Corp. share today touched a day high of $72.37 and a low of $69.52.
Boston Scientific Corp. share touched a 52 week high of $109.5 on and a 52 week low of $70.75 on . Boston Scientific Corp. stock price today i.e. is closed at $71.9,which is 34.34% down from its 52 week high and 1.63% up from its 52 week low.
Boston Scientific Corp. market capitalisation is $0.11T as on .
Indian investors can start investing in Boston Scientific Corp. (BSX) shares with as little as ₹92.306 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.06 in Boston Scientific Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Boston Scientific Corp. share’s latest price of $71.9 as on March 10, 2026 at 1:29 am IST, you will get 0.1391 shares of Boston Scientific Corp.. Learn more about
fractional shares .
Boston Scientific Corp. stock has given 80.4% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?